Long-term hepatic consequences of chemotherapy-related HBV reactivation in lymphoma patients

doi:10.3748/wjg.v11.i34.5283

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 34

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2734)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-3) series, Tables (1-3) series.

Item

Count

PDF

313

HTML

2040

Figures (1-3)

192

Tables (1-3)

189

Sum=2734

Sep 14, 2005 (publication date) through Nov 4, 2024

Times Cited of This Article

Times Cited (14)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Viral Hepatitis

World J Gastroenterol. Sep 14, 2005; 11(34): 5283-5288
Published online Sep 14, 2005. doi: 10.3748/wjg.v11.i34.5283

Full Size Figure Download Figure

Figure 1 OS of total 49 HBV carriers’ undergoing chemotherapy for non-Hodgkin’s lymphoma, according to HBV reactivation status (P = 0. 601) (A); comparison of liver reserve between HBV reactivators and HBV non-reactivators (P = 0.0342) (B).

Citation: Su WP, Wen CC, Hsiung CA, Su IJ, Cheng AL, Chang MC, Tsao CJ, Kao WY, Uen WC, Hsu C, Hsu CH, Lu YS, Tien HF, Chao TY, Chen LT, Whang-Peng J, Chen PJ. Long-term hepatic consequences of chemotherapy-related HBV reactivation in lymphoma patients. World J Gastroenterol 2005; 11(34): 5283-5288
URL: https://www.wjgnet.com/1007-9327/full/v11/i34/5283.htm
DOI: https://dx.doi.org/10.3748/wjg.v11.i34.5283